I agree that this site is using cookies. You can find further informations here.
X
Psyrri, A.
373  results:
Search for persons X
?
1

197MO Final outcome, immunophenotypic and biomarker analysi..:

Mountzios, G. ; Papadopoulou, K. ; Korfiatis, N....
ESMO Open.  9 (2024)  - p. 102770 , 2024
Link: https://doi.org/10.1016/..
 
?
2

B-cell infiltration is associated with survival outcomes fo..:

Gavrielatou, N. ; Fortis, E. ; Spathis, A....
Annals of Oncology.  35 (2024)  4 - p. 340-350 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Detection of hotspot PIK3CA mutations in primary tumors and..:

Smilkou, S. ; Stergiopoulou, D. ; Tzanikou, E....
Clinica Chimica Acta.  558 (2024)  - p. 119287 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Detection of PD-L1 MRNA expression in circulating tumor cel..:

Strati, A. ; Zavridou, M. ; Smilkou, S....
Clinica Chimica Acta.  558 (2024)  - p. 119285 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Real-world data on the safety and efficacy of trastuzumab d..:

Fountzilas, E. ; Lalla, T. ; Karakatsoulis, G....
European Journal of Cancer.  200 (2024)  - p. 113954 , 2024
Link: https://doi.org/10.1016/..
 
?
6

146P Long-term outcomes of patients with triple-negative br..:

Fountzilas, E. ; Zagouri, F. ; Karakatsoulis, G....
ESMO Open.  9 (2024)  - p. 103133 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Well-differentiated liposarcomas and dedifferentiated lipos..:

Kyriazoglou, A. ; Pagkali, A. ; Kotsantis, I....
Cancer Treatment Reviews.  125 (2024)  - p. 102716 , 2024
Link: https://doi.org/10.1016/..
 
?
8

113P Real-world data from patients with osteosarcoma treate..:

Moutafi, M. ; Kyriazoglou, A. ; Kotsantis, I....
ESMO Open.  9 (2024)  - p. 102502 , 2024
Link: https://doi.org/10.1016/..
 
?
9

263TiP Implementing geriatric assessment for dose optimizat..:

Valachis, A. ; Biganzoli, L. ; Christopoulou, A.N....
ESMO Open.  9 (2024)  - p. 103284 , 2024
Link: https://doi.org/10.1016/..
 
?
10

106P Treatment sequencing in PD-L1–positive recurrent/metas..:

Greil, R. ; Burtness, B. ; Laban, S....
Immuno-Oncology and Technology.  20 (2023)  - p. 100578 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Durvalumab with or without tremelimumab versus the EXTREME ..:

Psyrri, A. ; Fayette, J. ; Harrington, K....
Annals of Oncology.  34 (2023)  3 - p. 262-274 , 2023
Link: https://doi.org/10.1016/..
 
?
12

MA01.03 Thromboprophylaxis for Lung Cancer Patients: Combin..:

Tsoukalas, N.G. ; Christopoulou, A. ; Timotheadou, E....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S98 , 2023
Link: https://doi.org/10.1016/..
 
?
13

The effect of anthracycline-based chemotherapy on endotheli..:

Anastasiou, M ; Oikonomou, E ; Theofilis, P...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

Immune checkpoint inhibitors in sarcomas: a systematic revi..:

Anastasiou, M. ; Kyriazoglou, A. ; Kotsantis, I....
Immuno-Oncology and Technology.  20 (2023)  - p. 100407 , 2023
Link: https://doi.org/10.1016/..
 
?
15

31P Characterization of pre-exhausted/exhausted state of CD..:

Kotsantis, I. ; Economopoulou, P. ; Doumas, S....
Immuno-Oncology and Technology.  20 (2023)  - p. 100500 , 2023
Link: https://doi.org/10.1016/..
 
1-15